{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:35:47Z","timestamp":1761395747559,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.anndiagpath.2020.151534","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T17:22:33Z","timestamp":1589563353000},"page":"151534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide"],"prefix":"10.1016","volume":"46","author":[{"given":"Kwun Wah","family":"Wen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Fakhri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua","family":"Menke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ruiz-Cordero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Ohgami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151534_bb0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4149\/neo_2014_062","article-title":"Diffuse large B-cell lymphoma: the history, current view and new perspectives","volume":"61","author":"Flodr","year":"2014","journal-title":"Neoplasma"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0010","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199209000-00004","article-title":"Chronic lymphocytic leukemia\/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin\u2019s disease. Mediation by Epstein-Barr virus","volume":"16","author":"Momose","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00000478-199101000-00004","article-title":"Chronic lymphocytic leukemia with coexistent Hodgkin\u2019s disease. Implications for the origin of the Reed-Sternberg cell","volume":"15","author":"Williams","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0020","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/ajcp\/99.6.658","article-title":"Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage","volume":"99","author":"Shin","year":"1993","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e3182785610","article-title":"Peripheral T-cell lymphomas of follicular T-helper cell derivation with Hodgkin\/Reed-Sternberg cells of B-cell lineage: both EBV-positive and EBV-negative variants exist","volume":"37","author":"Nicolae","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cncr.27704","article-title":"Prognostic value of the follicular lymphoma international prognostic index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients","volume":"119","author":"Heilgeist","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0035","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00277-018-3516-1","article-title":"Validation of the marginal zone lymphoma international prognostic index","volume":"98","author":"Hong","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/annonc\/mdn657","article-title":"The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)","volume":"20","author":"Noy","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0045","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","article-title":"Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin\u2019s lymphoma","volume":"23","author":"Schoder","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0050","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3324\/haematol.12013","article-title":"Investigation of FDG-PET\/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma","volume":"93","author":"Bodet-Milin","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0055","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3324\/haematol.2010.022277","article-title":"Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (\u201caccelerated\u201d chronic lymphocytic leukemia) with aggressive clinical behavior","volume":"95","author":"Gin\u00e9","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/leu.2011.247","article-title":"Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays","volume":"26","author":"Ciccone","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0065","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1320-5463.2003.01455.x","article-title":"Richter syndrome in B-cell chronic lymphocytic leukemia","volume":"53","author":"Nakamura","year":"2003","journal-title":"Pathol Int"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cncr.20773","article-title":"Richter syndrome: biology, incidence, and therapeutic strategies","volume":"103","author":"Tsimberidou","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.seminoncol.2006.01.016","article-title":"Richter\u2019s transformation in chronic lymphocytic leukemia","volume":"33","author":"Tsimberidou","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0080","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1182\/blood-2010-09-302174","article-title":"The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0085","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/his.13024","article-title":"Diagnostic dilemmas of high-grade transformation (Richter\u2019s syndrome) of chronic lymphocytic leukaemia: results of the phase II National Cancer Research Institute CHOP-OR clinical trial specialist haemato-pathology central review","volume":"69","author":"Soilleux","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/ajh.10300","article-title":"Partially successful treatment of a patient with chronic lymphocytic leukemia and Hodgkin\u2019s disease: case report and literature review","volume":"72","author":"Adiga","year":"2003","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2141.2011.08907.x","article-title":"Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature","volume":"156","author":"Bockorny","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/ajh.23939","article-title":"Hodgkin transformation of chronic lymphocytic leukemia: incidence, outcomes, and comparison to de novo Hodgkin lymphoma","volume":"90","author":"Parikh","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0105","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.humpath.2016.04.019","article-title":"Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion","volume":"55","author":"Xiao","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0110","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S1470-2045(14)70153-6","article-title":"Pathogenesis, diagnosis, and treatment of composite lymphomas","volume":"15","author":"Kuppers","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0115","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/PAS.0b013e31804bdaf8","article-title":"IgVH mutational status and clonality analysis of Richter\u2019s transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution","volume":"31","author":"Mao","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"year":"2017","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","key":"10.1016\/j.anndiagpath.2020.151534_bb0125"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0130","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/annonc\/mdq574","article-title":"Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy","volume":"22","author":"Shustik","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0135","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.pas.0000172191.87176.3b","article-title":"Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features","volume":"29","author":"Wang","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0140","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/MO:18:1:15","article-title":"Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma","volume":"18","author":"Llanos","year":"2001","journal-title":"Med Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0145","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-14-153","article-title":"Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis","volume":"14","author":"He","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0150","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2009.26.1693","article-title":"Prognostic factors in follicular lymphoma","volume":"28","author":"Relander","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0155","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.cmonc.2012.09.015","article-title":"Considerations in the initial management of follicular lymphoma","volume":"9","author":"Nastoupil","year":"2012","journal-title":"Community Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0160","doi-asserted-by":"crossref","first-page":"e2016041","DOI":"10.4084\/mjhid.2016.041","article-title":"Limited stage follicular lymphoma: current role of radiation therapy","volume":"8","author":"Filippi","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.beha.2011.03.005","article-title":"Radioimmunotherapy in follicular lymphoma","volume":"24","author":"Illidge","year":"2011","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0170","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/annonc\/mdx392","article-title":"Revival of PI3K inhibitors in non-Hodgkin\u2019s lymphoma","volume":"28","author":"Batlevi","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0175","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/1060028019833992","article-title":"Copanlisib: an intravenous phosphatidylinositol 3-kinase (PI3K) inhibitor for the treatment of relapsed follicular lymphoma","volume":"53","author":"Eltantawy","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0180","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2015-11-624320","article-title":"The role of autologous and allogeneic stem cell transplantation in the management of indolent B-cell lymphoma","volume":"127","author":"Kuruvilla","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.2019001843","article-title":"The case for CAR T-cell therapy in follicular lymphomas","volume":"134","author":"Bishop","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0190","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2353\/jmoldx.2006.060016","article-title":"The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations","volume":"8","author":"Tan","year":"2006","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0195","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2015.09.033","article-title":"An analysis of MYC and EBV in diffuse large B-cell lymphomas associated with angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma not otherwise specified","volume":"48","author":"Hoffmann","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0200","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1309\/72CM-KAXF-66DE-4XVA","article-title":"Peripheral T-cell lymphoma complicated by a proliferation of large B cells","volume":"114","author":"Higgins","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0205","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/00000478-199910000-00008","article-title":"Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection","volume":"23","author":"Quintanilla-Martinez","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0210","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3324\/haematol.2011.061507","article-title":"Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA","volume":"97","author":"Delfau-Larue","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0215","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2012-06-439455","article-title":"Aberrant T-cell antigen expression in classical Hodgkin lymphoma is associated with decreased event-free survival and overall survival","volume":"121","author":"Venkataraman","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0220","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/PAS.0b013e318268d9ff","article-title":"Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics","volume":"36","author":"Moroch","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0225","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/PAS.0000000000000813","article-title":"Clinicopathological study of 30 cases of peripheral T-cell lymphoma with Hodgkin and Reed-Sternberg-like B-cells from Japan","volume":"41","author":"Eladl","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0230","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0235","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/PAS.0b013e318241f050","article-title":"Cyclin D1-negative blastoid mantle cell lymphoma identified by SOX11 expression","volume":"36","author":"Zeng","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0240","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/his.13161","article-title":"Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall","volume":"70","author":"Chuang","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0245","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/jclinpath-2015-202955","article-title":"CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series","volume":"68","author":"Akhter","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0250","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1309\/UD2C6JVPWHXQQ217","article-title":"An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10","volume":"122","author":"Morice","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0255","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.pas.0000128671.92609.af","article-title":"Aberrant Bcl6 protein expression in mantle cell lymphoma","volume":"28","author":"Camacho","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0260","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2559.2012.04260.x","article-title":"SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma","volume":"61","author":"Hsiao","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0265","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/bjh.12854","article-title":"SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma--a Nordic lymphoma group study","volume":"166","author":"Nordstrom","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0270","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1182\/blood-2011-12-400580","article-title":"Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma","volume":"119","author":"Nygren","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0275","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European mantle cell lymphoma network","volume":"34","author":"Hoster","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0280","first-page":"128","article-title":"Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma)","volume":"36","author":"Nathwani","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0285","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0290","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00000478-200306000-00006","article-title":"Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases","volume":"27","author":"Camacho","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1349-7006.2006.00345.x","article-title":"Clinical implications of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases","volume":"98","author":"Kojima","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0300","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2559.2005.02309.x","article-title":"A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases","volume":"48","author":"Traverse-Glehen","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0305","first-page":"200","article-title":"Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup","volume":"90","author":"Petit","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0310","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/bjh.14228","article-title":"Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era","volume":"175","author":"Starr","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0315","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1200\/JCO.2006.07.5671","article-title":"Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis","volume":"24","author":"Ghesquieres","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151534_bb0320","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/his.12092","article-title":"Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases","volume":"62","author":"Traverse-Glehen","year":"2013","journal-title":"Histopathology"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:33:41Z","timestamp":1761078821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420300757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":64,"alternative-id":["S1092913420300757"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151534","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151534","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151534"}}